3 completed. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 3 | 1 | Completed 1 |
Follow Schizophreniform Disorders: new trials by email Literature Review of Schizophreniform Disorders trials Research Report on Schizophreniform Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar Disorder BXCL501 Sublingual Film - Bipolar I Disorder, Bipolar II Disorder | Phase 2 | Completed | BioXcel Therapeutics Inc | 33 | 2025-06-19 | 2026-10-05 |
| Sodium Benzoate and/or N-Acetylcysteine Added to TAU in Patients With Early Schizophrenia Spectrum Disorder. Sodium Benzoate, N-Acetylcysteine, Placebo - Schizophrenia, Schizophreniform Disorders | Phase 2 | Completed | Pakistan Institute of Living and Learning | 64 | 2019-01-01 | 2022-04-27 |
| Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants Ethyl-eicosapentaenoic acid (EPA), Vitamins E + C, Etyl EPA (placebo) - Schizophrenia, Schizophreniform Disorders | Phase 2 / Phase 3 | Completed | University Hospital, Aker | 99 | 2001-09-01 | 2011-01-04 |
Psychotic Disorders (3) · Schizophrenia (3) · Bipolar Disorder (1) · Delusions (1) · Hallucinations (1) · Hypertriglyceridemia (1) · Inflammation (1) · Psychomotor Agitation (1)
Mental Disorders (3) · Pathological Conditions, Signs and Symptoms (3) · Schizophrenia Spectrum and Other Psychotic Disorders (3) · Behavior (2) · Behavioral Symptoms (2) · Nervous System Diseases (2) · Neurobehavioral Manifestations (2) · Neurologic Manifestations (2) · Signs and Symptoms (2) · Aberrant Motor Behavior in Dementia (1) · Bipolar and Related Disorders (1) · Dyskinesias (1) · Dyslipidemias (1) · Hyperlipidemias (1) · Lipid Metabolism Disorders (1)
Acetylcysteine (1) · Dexmedetomidine (1) · Sodium Benzoate (1) · eicosapentaenoic acid ethyl ester (1)
BioXcel Therapeutics Inc (1) · Pakistan Institute of Living and Learning (1) · University Hospital, Aker (1)
Norway (1) · Pakistan (1) · United States (1)
BioXcel MM (1) · Imran B Chaudhry, MD (1)